Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

NCT04993885 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia
Autoantibodies
Evan Syndrome
Connective Tissue Diseases

Interventions

DRUG: Avatrombopag

Sponsor

Institute of Hematology & Blood Diseases Hospital, China